Study Confirms Link Between Atypical Femur Fractures and Fosamax Use
Ennis & Ennis, PA Summarizes the Latest Fosamax Study that Confirms Long-Term Use of Biphosphonates, such as Fosamax and Boniva, Causes Atypical Femur Fractures (PRWEB) May 26, 2012 After the New England Journal of Medicine published their findings that use of biphosphonates is not deemed beneficial outside of a 3 to 5 year window, the Archives of Internal Medicine have confirmed that prolonged use of the drug increases risk for atypical fractures of the femur. Commonly used brand names of the drug are Fosamax, Reclast, Boniva, and Actonel. In the past few years the FDA has increased t
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 312
- Bankruptcy 44
- Business 134
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 609
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4